Quest Diagnostics IncorporatedDGXNYSE
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank86
5Y CAGR-24.5%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
-24.5%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
20258.60%
20245.70%
2023-10.60%
2022-18.44%
202115.85%
202035.11%
20193.22%
2018-12.88%
20173.14%
20162.22%